Home/Federal Circuit/Andrulis Pharmaceuticals Corp. v. Celgene Corp.

Andrulis Pharmaceuticals Corp. v. Celgene Corp.

667 F. App'x 775
CourtCourt of Appeals for the Federal Circuit
DecidedJuly 14, 2016
Docket2015-1962
StatusPublished

This text of 667 F. App'x 775 (Andrulis Pharmaceuticals Corp. v. Celgene Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Andrulis Pharmaceuticals Corp. v. Celgene Corp., 667 F. App'x 775 (Fed. Cir. 2016).

Opinion

JUDGMENT

Per Curiam

(Prost, Chief Judge, Schall and Chen, Circuit Judges).

This Cause having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
667 F. App'x 775, Counsel Stack Legal Research, https://law.counselstack.com/opinion/andrulis-pharmaceuticals-corp-v-celgene-corp-cafc-2016.